fda drug safety communication semaglutide naion 2025 The obesity (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added FDA Decisions Expected: October 2025

My biggest side effect was nausea, which still wasnt that big

In clinical trials, the most common observations were gastrointestinal effects: nausea (44.2% vs 17.4% placebo in STEP 1), diarrhea (30.0%), vomiting (24.8%), and constipation (24.2%)

Your health care professional will tell you what goal is right for you

Consumer Safety Note SEMALIX 14 TABLET should only be taken under a doctors supervision

I didnt actually want to go this thin, but it just happened and Ill probably put it all on again soon. She added that she experienced nausea as a side effect You dont throw up physically but youve got that feeling," she said